SCHEMBL22792816

SCHEMBL22792816

CC(C)(C)C1=C(C(C)(C)C)NSC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22792895 0.59 — —
SCHEMBL22792661 0.59 — —
SCHEMBL22793177 0.46 — —
SCHEMBL8215570 0.41 — —
SCHEMBL50659 0.40 ALDH1A1 (0.38) —
SCHEMBL424728 0.39 TSHR (0.73) —
SCHEMBL93161 0.39 GABRA1 (0.69) —
SCHEMBL7132801 0.39 ALDH1A1 (0.53) —
SCHEMBL9537161 0.38 — —
SCHEMBL10287789 0.38 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117015566-A Stabilizer composition, use of a stabilizer composition, method for stabilizing polycondensates against hydrolytic degradation, and hydrolytically stable compositions and mouldings or mouldings thereof 弗劳恩霍夫应用研究促进协会 2023-11-07 — — CN disclosed
US-10988466-B2 Heterocyclic derivatives useful as SHP2 inhibitors JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2021-04-27 — — US disclosed
US-20200392128-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2020-12-17 — — US disclosed
Send feedback